In lung squamous cell carcinoma and lung adenocarcinoma, EZH2 expression is positively correlated with BRAF (r = 0.2397, p < 0.0001) and KRAS (r = 0.3167, p < 0.001) gene expression (Fig. 4A, G). Here, EZH2 is linked to squamous cell lung carcinoma.